MedPath

Formulation and standardization of Yazd Meybod ethno-topical preparation made from cotton (Gossypium herbaceum L.) to evaluate the effect on cutaneous Leishmaniasis, a randomized, double blind, placebo controlled trial.

Phase 3
Recruiting
Conditions
cutaneous leishmaniasis.
Cutaneous leishmaniasis
B55.1
Registration Number
IRCT20220131053899N1
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
70
Inclusion Criteria

Cannot be using any kind of therapy for leishmaniasis
No lesions with a diameter bigger than 3 centimeters
Have no kind of immune deficiency diseases
No lesions located on the face or joints and have less than 5 lesions
Patients with less than 5 ulcers

Exclusion Criteria

Any severe side effects or allergies
Patients that do not apply the remedy daily or perform the protocol correctly

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
lcer diameter. Timepoint: 30 days after starting treatment. Method of measurement: caliper.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath